SYSMEX CORP.UNSP.ADR 1/2 - Asset Resilience Ratio
SYSMEX CORP.UNSP.ADR 1/2 (0YX0) has an Asset Resilience Ratio of 0.05% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Also explore 0YX0 asset base for the complete picture of this company's asset base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2025)
This chart shows how SYSMEX CORP.UNSP.ADR 1/2's Asset Resilience Ratio has changed over time. See SYSMEX CORP.UNSP.ADR 1/2 net asset quality index to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down SYSMEX CORP.UNSP.ADR 1/2's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 0YX0 stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €351.00 Million | 0.05% |
| Total Liquid Assets | €351.00 Million | 0.05% |
Asset Resilience Insights
- Limited Liquidity: SYSMEX CORP.UNSP.ADR 1/2 maintains only 0.05% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
SYSMEX CORP.UNSP.ADR 1/2 Industry Peers by Asset Resilience Ratio
Compare SYSMEX CORP.UNSP.ADR 1/2's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Xiangyu Medical Co. Ltd. A
SHG:688626 |
Medical Devices | 1.53% |
|
Xvivo Perfusion AB
ST:XVIVO |
Medical Devices | 12.30% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Beijing Chunlizhengda Medical Instruments Co Ltd
SHG:688236 |
Medical Devices | 25.01% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Guangdong Transtek Medical Electronics Co Ltd
SHE:300562 |
Medical Devices | 14.72% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
|
PetVivo Holdings Inc
NASDAQ:PETV |
Medical Devices | 2.18% |
Annual Asset Resilience Ratio for SYSMEX CORP.UNSP.ADR 1/2 (2022–2025)
The table below shows the annual Asset Resilience Ratio data for SYSMEX CORP.UNSP.ADR 1/2.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 0.10% | €654.00 Million ≈ $764.59 Million |
€665.27 Billion ≈ $777.77 Billion |
-0.11pp |
| 2024-03-31 | 0.21% | €1.31 Billion ≈ $1.53 Billion |
€618.92 Billion ≈ $723.58 Billion |
+0.05pp |
| 2023-03-31 | 0.16% | €875.00 Million ≈ $1.02 Billion |
€531.07 Billion ≈ $620.88 Billion |
-0.14pp |
| 2022-03-31 | 0.31% | €1.50 Billion ≈ $1.75 Billion |
€483.71 Billion ≈ $565.50 Billion |
-- |
About SYSMEX CORP.UNSP.ADR 1/2
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers non-clinical blood testing and cell analysis for hematology, such as XN-V series, a software for laboratory animal corresponding to XN series fully automated hematology analyzers; XN-Series, a fully automated flagship hematology analyzers; and Automated hematol… Read more